About
Bio
Background and Format:
EP Vantage was launched in 2007 by EvaluatePharma, a source for pharma and biotech analysis. Their unique access to EvaluatePharma Alpha’s Calendar of Events allows coverage of potential market catalysts weeks and even months ahead of other industry sources while Alpha’s NPV (Net Present Value) Analyzer aims to put events into context, quantifying the impact on product and company valuation.
EP Vantage aims to provide timely financial analysis of regulatory and patent decisions, marketing approvals, licensing deals, and M&A, giving fresh angles and insight to both current and future industry triggers.
Audience and Readership:
EP Vantage is targeted at people working in the global pharmaceutical industry.
Deadline:
Ongoing (website).
Monthly Unique Users:
This figure is not disclosed by the publisher.
Awards:
2011 - European Mediscience Awards, Commentator of the Year (Winner)
Gorkana Alert: Wednesday 10 June 2015
Madeleine Armstrong is now Reporter at EP Vantage. Previously Deputy Editor at Clinica, she will be covering the pharmaceuticals and medical technology sectors. Madeleine can be reached at madeleinea@epvantage.com and can be also found tweeting at www.twitter.com/medtech_ma
Gorkana alert: Wednesday 30th April 2008
EP Vantage, the comment and analysis service for the pharma and biotech industries, has launched its new website www.epvantage.com. Targeted at the financial community and senior pharmaceutical executives, EP Vantage offers in-depth financial commentary and analysis on a wide range of issues including patent litigation, M&A, licensing and product approvals. As part of the launch of epvantage.com new users are eligible for a limited free trial. EP Vantage, part of EvaluatePharma, is edited by Lisa Urquhart, former Biotechnology Correspondent at the Financial Times. Lisa can be reached on +44 (0)20 7539 1819 and lisau@epvantage.com
Gorkana Alert: Monday 13th August 2007
Lisa Urquhart, formerly Biotechnology Correspondent at the Financial Times, is Editor of EP Vantage, a new online financial news and analysis service for the pharmaceutical and biotechnology sectors. Lisa is joined by Amy Brown, most recently a Reporter at Thomson Financial News, covering biotechnology and pharmaceutical. Amy starts today as Senior Reporter. The editorial team also includes Christian Glennie, Senior Editorial Analyst from EvaluatePharma, who has over six years experience as a pharmaceutical analyst.
Set to launch in autumn 2007, EP Vantage will offer in-depth financial commentary and analysis of a wide range of industry issues and trends. It will be targeted at senior pharmaceutical executives, hedge fund managers, investment banks, advisers and public and private company investors.
The EP Vantage editorial team can be reached on the following numbers and email addresses:
Lisa Urquhart, Editor, lisau@epvantage.com and +44 (0)20 7539 1819
Amy Brown, amyb@epvantage.com and +44 (0)20 7539 1808
Christian Glennie,
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Healthcare Industry, Healthcare, Pharmaceuticals, Biotechnology
Bio
Background and Format: EP Vantage was launched in 2007 by EvaluatePharma, a source for pharma and biotech analysis. Their unique access to EvaluatePharma Alpha’s Calendar of Events allows coverage of potential market catalysts weeks and even months ahead of other industry sources while Alpha’s NPV (Net Present Value) Analyzer aims to put events into context, quantifying the impact on product and company valuation. EP Vantage aims to provide timely financial analysis of regulatory and patent decisions, marketing approvals, licensing deals, and M&A, giving fresh angles and insight to both current and future industry triggers. Audience and Readership: EP Vantage is targeted at people working in the global pharmaceutical industry. Deadline: Ongoing (website). Monthly Unique Users: This figure is not disclosed by the publisher. Awards: 2011 - European Mediscience Awards, Commentator of the Year (Winner) Gorkana Alert: Wednesday 10 June 2015 Madeleine Armstrong is now Reporter at EP Vantage. Previously Deputy Editor at Clinica, she will be covering the pharmaceuticals and medical technology sectors. Madeleine can be reached at madeleinea@epvantage.com and can be also found tweeting at www.twitter.com/medtech_ma Gorkana alert: Wednesday 30th April 2008 EP Vantage, the comment and analysis service for the pharma and biotech industries, has launched its new website www.epvantage.com. Targeted at the financial community and senior pharmaceutical executives, EP Vantage offers in-depth financial commentary and analysis on a wide range of issues including patent litigation, M&A, licensing and product approvals. As part of the launch of epvantage.com new users are eligible for a limited free trial. EP Vantage, part of EvaluatePharma, is edited by Lisa Urquhart, former Biotechnology Correspondent at the Financial Times. Lisa can be reached on +44 (0)20 7539 1819 and lisau@epvantage.com Gorkana Alert: Monday 13th August 2007 Lisa Urquhart, formerly Biotechnology Correspondent at the Financial Times, is Editor of EP Vantage, a new online financial news and analysis service for the pharmaceutical and biotechnology sectors. Lisa is joined by Amy Brown, most recently a Reporter at Thomson Financial News, covering biotechnology and pharmaceutical. Amy starts today as Senior Reporter. The editorial team also includes Christian Glennie, Senior Editorial Analyst from EvaluatePharma, who has over six years experience as a pharmaceutical analyst. Set to launch in autumn 2007, EP Vantage will offer in-depth financial commentary and analysis of a wide range of industry issues and trends. It will be targeted at senior pharmaceutical executives, hedge fund managers, investment banks, advisers and public and private company investors. The EP Vantage editorial team can be reached on the following numbers and email addresses: Lisa Urquhart, Editor, lisau@epvantage.com and +44 (0)20 7539 1819 Amy Brown, amyb@epvantage.com and +44 (0)20 7539 1808 Christian Glennie,
Website
Social media
Location
Frequency
Circulation
Sectors
Healthcare Industry, Healthcare, Pharmaceuticals, Biotechnology
Most recent articles by Evaluate Vantage
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Evaluate Vantage
-
TThe New York Times
The New York Times is an American daily news organization headquartered in New York City. It produces national and international journalism across print and digital platforms, covering topics including politics, business, technology, science, culture, and global affairs. The organization maintains a global network of bureaus and correspondents that contribute reporting from the United States and abroad. It publishes a daily print edition and continuously updates its digital platforms throughout the day with breaking news and feature reporting.
ViewTThe Boston GlobeThe Boston Globe focuses on news for the general public in the New England area as well as state, national and international news. Other coverage areas include business, healthcare, technology, features, lifestyle, arts and sports. There is also an emphasis on regional and suburban coverage. Lead times vary depending on the department.
ViewBBBC World ServiceThe BBC World Service is the international broadcasting arm of the BBC. It is available around the world on analogue and digital shortwave platforms, internet streaming, podcasting, satellite, DAB, FM and MW relays. The broadcaster is available in more than 40 languages in addition to English. BBC World Service English has eight regional feeds: East and South Africa; West and Central Africa; Europe and Middle East; the Americas and Caribbean; East Asia; South Asia; Australasia; and the United Kingdom.
ViewAAxiosAxios is a website which focused on delivering clear, concise, and fact-based reporting on the most important topics shaping the world. The outlet covers politics, business, technology, science, health, climate, and culture, aiming to keep readers informed quickly and accurately.
ViewPPress AssociationThe Press Association (PA) is a UK-based news agency that provides news and information to media organisations, businesses and other clients. It covers a range of topics, including national and international news, politics, business, sport, entertainment, and regional and local events. Its journalists gather information through interviews, official statements, press conferences, public records and other reporting activities. The agency produces news reports, photographs, videos and other multimedia content for use by newspapers, broadcasters and online publications. Its services support media organisations in reporting on current affairs and events across the UK and internationally.
ViewUse CisionOne to find more relevant outletsContact Evaluate Vantage and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.